Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in Perennial Allergic Rhinitis
NCT00974571Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Nov 2001
- Primary completion
- May 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of montelukast in perennial allergic rhinitis (PAR), sponsored by Organon & Co.. Started Nov 2001; status: completed.
02
Drugs
montelukast
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00974571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00974571.